provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
HomeDrugsOcrevus

Ocrevus Infusion Dosage for Multiple Sclerosis: Your GoodRx Guide

Alex Evans, PharmD, MBAAustin Ulrich, PharmD, BCACP
Published on March 1, 2024

Key takeaways:

  • Ocrevus (ocrelizumab) is a biologic medication used to treat multiple sclerosis (MS). It’s administered as an infusion, meaning you’ll receive it intravenously (in your veins) over about 2 to 4 hours. And you’ll be monitored for at least 1 hour afterward.

  • The first two Ocrevus doses are given 2 weeks apart. After that, you’ll receive an infusion every 6 months. How long your infusions last will depend on whether you experience infusion reactions.

  • To make your infusion experience more comfortable, wear loose-fitting clothing and bring along activities to help pass the time. You can also check with your infusion site to see if you’re able to bring water and snacks with you.

An illustration depicts a gloved hand holding a medication vial against a green, graph-paper background.
GoodRx Health

Ocrevus (ocrelizumab) is a biologic medication that’s approved to treat relapsing-remitting and primary progressive forms of multiple sclerosis (MS). It can slow the progression of MS and lessen the frequency and severity of flare-ups. If you’re prescribed Ocrevus, you’ll receive it as an IV infusion.

When preparing for your first Ocrevus infusion, you may have questions about how long the infusions take and what happens if you can’t make one of your appointments. We cover these topics, along with typical Ocrevus dosages, below.

What to expect when starting Ocrevus infusions

Before you start treatment with Ocrevus, your healthcare team will run a few tests to make sure that it’s safe for you to receive the medication. This includes testing for the hepatitis B virus (HBV), since Ocrevus can reactivate or make it harder to fight off an HBV infection. They’ll also measure immunoglobulins (antibodies) in your blood. If your levels are too low, you may not be able to receive Ocrevus.

You should plan on spending between 4 to 6 hours at your infusion site when you receive your Ocrevus infusions. The infusions themselves usually last between 2 to 4 hours. But you’ll receive a check-up and medications before the infusions start. Then, you’ll be monitored for about 1 hour afterward.

To help make your Ocrevus infusion appointments more comfortable, here are a few tips:

  • Wear loose-fitting, comfortable clothing that allows staff easy access to your arm for the infusion.

  • Bring water and your favorite snacks, if allowed by your infusion site.

  • Pack items that can help you pass the time, such as books, magazines, or a laptop.

  • Bring along a pillow and/or blanket.

Keep in mind: Make sure to let the infusion center know if you’re sick on your infusion day. In this case, they’ll likely cancel your appointment and reschedule it after you’ve recovered. 

What’s the typical Ocrevus dosage?

Your first Ocrevus treatment will be split into two doses, which are administered 2 weeks apart. You’ll receive a 300 mg dose over the course of 2.5 hours during each of the two infusion sessions.

After that, you’ll receive a 600 mg dose every 6 months. Each of these infusions will be given over 2 to 4 hours. Exactly how long they take will depend on whether infusion reactions occur. Infusion reactions can range from mild to severe and cause symptoms such as itching, shortness of breath, and nausea. In rare cases, Ocrevus can cause serious allergic reactions (anaphylaxis) that need to be treated immediately.

You’ll be monitored for at least 1 hour after your Ocrevus infusion for reactions. But they can sometimes happen later on, even after you’ve left the infusion site. Contact your healthcare team right away if you develop any new or worsening symptoms within 24 hours of your infusion. Get immediate medical attention if your symptoms feel severe or life-threatening.

Are there any dosage adjustments for certain situations?

There aren’t any scenarios in which the total amount of Ocrevus you receive during an infusion would be adjusted due to a medical condition, such as liver problems. But how quickly the medication is infused can vary depending on certain factors.

If you don’t have infusion reactions with Ocrevus, your infusions typically go faster. But if you develop a reaction, the infusion staff may need to slow down how quickly the medication is being infused. And if your reaction is severe, the infusion may be stopped temporarily until your symptoms resolve. In the case of a life-threatening reaction, the infusion will be discontinued altogether.

What happens if you miss an Ocrevus infusion?

If you miss an Ocrevus infusion, contact your healthcare team as soon as possible to reschedule. Keep in mind that there are certain situations, such as when you’re sick, in which you should reschedule. But in general, it’s best to stick to your usual schedule as much as possible.

The bottom line

Ocrevus (ocrelizumab) is a biologic medication used to treat multiple sclerosis (MS). The initial Ocrevus treatment is given as two 300 mg doses, which are administered 2 weeks apart. After that, the standard dosage is 600 mg every 6 months. How long the infusions take can vary, depending on whether you have an infusion reaction.

Before starting treatment with Ocrevus, your healthcare team will test you for the hepatitis B virus (HBV) and check your immunoglobulin levels. Let your infusion site know if you’re sick before an infusion appointment, since you may need to reschedule.

why trust our exports reliability shield

Why trust our experts?

Alex Evans, PharmD, MBA
Alex Evans, PharmD, MBA, has been a pharmacist for 12 years. His first job was floating in a community chain pharmacy.
Alyssa Billingsley, PharmD
Alyssa Billingsley, PharmD, is the director of pharmacy content for GoodRx. She has over a decade of experience as a pharmacist and has worked in clinical, academic, and administrative roles.
Austin Ulrich, PharmD, BCACP
Austin Ulrich, PharmD, BCACP, is a board-certified ambulatory care clinical pharmacist. In his early career, he provided direct patient care in a variety of settings, including hospital and community pharmacies, and in a primary care clinic as a clinical pharmacist.

References

Genentech, Inc. (2024). Ocrevus (ocrelizumab) injection [package insert]

Genentech USA, Inc. (2022). First infusion guide | Ocrevus (ocrelizumab).

View All References (1)

Justiz Vaillant, A. A., et al. (2023). Immunoglobulin. StatPearls.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

Subscribe and save.

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up.

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.